Physician profile
Mona M Shete
NPI 1265736607
$1,916.26
in general payments reported to CMS, 2019-2025
12 companies · $133 in 2025
The $133 reported for 2025 was less than what a typical Plastic Surgery Within The Head & Neck provider received nationally (typical 2025 total: $238).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $243 · 2020: $1,028 · 2021: $298 · 2022: $132 · 2023: $22.77 · 2024: $60.14 · 2025: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $216.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $1,027.76 | 2020 | |
| Optinose US, INC. | $236.13 | 2019-2022 | |
| Medtronic, INC. | $194.04 | 2021-2022 | |
| Intersect Ent, INC. | $135.58 | 2019 | |
| Inspire Medical Systems, INC. | $123.05 | 2024-2025 | Inspire |
| Atos Medical INC | $68.94 | 2019 | |
| Boston Scientific Corporation | $33.02 | 2024 | Lumenis Pulse 120h |
| Teleflex LLC | $23.13 | 2025 | Urolift |
| Acclarent, INC | $22.77 | 2023 | Acclarent Aera |
| Stryker Corporation | $20.34 | 2019 | |
| Smith+Nephew, INC. | $17.32 | 2021 | |
| Merck Sharp & Dohme LLC | $14.18 | 2025 | Bridion |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mona Shete listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.